If you are wondering whether Pfizer's current share price still reflects its long term potential, this article will help you ...
What Pfizer’s recent performance tells you right now Pfizer (PFE) has drawn fresh attention after a period in which the share ...
Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...
The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.
Is Pfizer stock a buy at under 9x earnings? Yes. It is.
Dividend investors are likely to find the stock's 6.7% yield attractive. That yield is the result of a 100% dividend payout ratio -- meaning the company devotes all its profit to the payments -- so ...
Pfizer PFE faces patent expirations amounting to more than one quarter of 2024 revenue by 2028, and the 2023 acquisition of oncology-focused biotech Seagen boosted the firm’s invested capital base, ...
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the ...
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.